OFFICIAL PUBLICATION OF

by its subsidiary APPco

Making the cut

Chris Brooker 16/04/2017

What are likely to be the top 10 drug launches of 2017? 2016 was an "unusually slow year" for drug approvals, according to US industry website Fierce Pharma. However, analysts are still predicting a range of new 'blockbuster' drug launches. Heading the list, according to EP Vantage’s 2017 preview, which ranks the year’s rollouts by

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Making the cut

Previous How multi-millionaire pharmacists manage their time

Next Is Australia ready for an infectious disease emergency?

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous How multi-millionaire pharmacists manage their time

Next Is Australia ready for an infectious disease emergency?

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.